Autonomix Medical says two transvascular technology abstracts accepted for CIRSE 2026 posters

PUBT · 3d ago
Autonomix Medical says two transvascular technology abstracts accepted for CIRSE 2026 posters
  • Autonomix Medical disclosed acceptance of two clinical research abstracts for poster presentation at the CIRSE 2026 congress.
  • Results have not been presented yet; posters are scheduled for September 5-9, 2026, in Copenhagen.
  • One study reports long-term findings suggesting transvascular RF denervation may help mitigate pain in pancreatic adenocarcinoma.
  • The second presentation outlines use of the same platform for precision-guided mapping of neural structures to support nerve-targeted interventions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609010830PRIMZONEFULLFEED9818964) on September 01, 2026, and is solely responsible for the information contained therein.